Pyroptosis in glioblastoma: A crucial regulator of the tumour immune microenvironment and a predictor of prognosis. Issue 5 (26th January 2022)
- Record Type:
- Journal Article
- Title:
- Pyroptosis in glioblastoma: A crucial regulator of the tumour immune microenvironment and a predictor of prognosis. Issue 5 (26th January 2022)
- Main Title:
- Pyroptosis in glioblastoma: A crucial regulator of the tumour immune microenvironment and a predictor of prognosis
- Authors:
- Lin, Jinhu
Lai, Xiang
Liu, Xiaoping
Yan, Hua
Wu, Changwu - Abstract:
- Abstract: Recent studies have shown that pyroptosis, an inflammatory form of cell death, has a dual role in tumorigenesis and tumour progression and affects the prognosis of patients; however, the role of pyroptosis in glioblastoma (GBM) is still unclear. In this study, based on GBM patients' data from two independent cohorts, we performed a comprehensive analysis of the expression and prognostic value of 33 pyroptosis‐associated genes (PAGs) in GBM, as well as their role in the tumour immune microenvironment (TIME) of GBM. We identified 29 PAGs that were differentially expressed between GBM and normal brain tissue, 18 of which were upregulated in GBM tissue. Most of the 33 PAGs were strongly correlated with the levels of immune cell infiltration. Based on the 33 PAGs, the GBM samples can be divided into two clusters (C1‐C2), with C1 having a 'hot' but immunosuppressive TIME and C2 having a 'cold' TIME, suggesting different immunotherapeutic responses in the two clusters. In addition, we identified four PAGs that were strongly associated with GBM prognosis and constructed a risk model based on these four PAGs. This risk model is an independent prognostic factor for GBM patients, and there is a different immune status between high‐ and low‐risk groups. In conclusion, this study demonstrates that pyroptosis is closely associated with the prognosis and TIME of GBM and provides an important basis for further studies on the relationship between pyroptosis and GBM.
- Is Part Of:
- Journal of cellular and molecular medicine. Volume 26:Issue 5(2022)
- Journal:
- Journal of cellular and molecular medicine
- Issue:
- Volume 26:Issue 5(2022)
- Issue Display:
- Volume 26, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 26
- Issue:
- 5
- Issue Sort Value:
- 2022-0026-0005-0000
- Page Start:
- 1579
- Page End:
- 1593
- Publication Date:
- 2022-01-26
- Subjects:
- glioblastoma -- prognosis -- pyroptosis -- risk model -- tumour immune microenvironment
Cytology
Medicine
Molecular Biology
Cytologie -- Périodiques
Médecine -- Périodiques
Biologie moléculaire -- Périodiques
Cytology -- Periodicals
Medicine -- Periodicals
Molecular biology -- Periodicals
611.01805 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1582-4934 ↗
http://www.blackwell-synergy.com/loi/jcmm ↗
http://www.usc.edu/hsc/nml/e-resources/info/joucelmm.html ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/jcmm.17200 ↗
- Languages:
- English
- ISSNs:
- 1582-1838
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4955.005000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21010.xml